David Richard Light

Illexcor Therapeutics, LLC

NIH Rank #7154
  • Early Career

NIH Funding · FY2024

Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#7,154
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.7M across 2 grants · National rank #7154.

Top grants by award amount

David Richard Light's NIH grant portfolio, ranked by award amount.

  • 5R44HL154864-03R44
    Rapid Development of a Lead Aromatic Aldehyde Derivative with both Oxygen Dependent and Novel, Oxygen Independent Anti-Sickling Effects: Building on a Paradigm Shift in Sickle Cell Disease Therapy
    $887.9K
    award amount
  • 5R44HL156334-03R44
    Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier
    $807.8K
    award amount

Affiliation

Institutions that have administered grants for David Richard Light.

Affiliated with Illexcor Therapeutics, LLC (VA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Illexcor Therapeutics, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7154